tolvaptan has been researched along with taurocholic acid in 1 studies
Studies (tolvaptan) | Trials (tolvaptan) | Recent Studies (post-2010) (tolvaptan) | Studies (taurocholic acid) | Trials (taurocholic acid) | Recent Studies (post-2010) (taurocholic acid) |
---|---|---|---|---|---|
967 | 172 | 786 | 3,789 | 26 | 654 |
Protein | Taxonomy | tolvaptan (IC50) | taurocholic acid (IC50) |
---|---|---|---|
Sodium-dependent dopamine transporter | Rattus norvegicus (Norway rat) | 6 | |
Sodium/bile acid cotransporter | Rattus norvegicus (Norway rat) | 6 | |
Sodium/bile acid cotransporter | Homo sapiens (human) | 5.3 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brock, WJ; Brouwer, KL; Brouwer, KR; Freeman, KM; Lu, Y; Pan, M; Slizgi, JR; St Claire, RL | 1 |
1 other study(ies) available for tolvaptan and taurocholic acid
Article | Year |
---|---|
Inhibition of Human Hepatic Bile Acid Transporters by Tolvaptan and Metabolites: Contributing Factors to Drug-Induced Liver Injury?
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Carrier Proteins; Chemical and Drug Induced Liver Injury; CHO Cells; Cricetulus; Hepatocytes; Humans; Membrane Glycoproteins; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Polycystic Kidney, Autosomal Dominant; Taurocholic Acid; Tolvaptan | 2016 |